Healthcare optimized.
Living life redefined.

GLP-1 weight loss treatment online follows a structured medical workflow: consultation, prescription when appropriate, and coordinated medication fulfillment. Unlike retail supplements, this path is led by licensed clinicians who review your history before any treatment begins.

Consult → prescription → medication

You complete a secure intake covering demographics, weight history, medications, and contraindications. A physician reviews asynchronously—typically within 24 hours—and determines whether GLP-1 therapy is appropriate. If approved, a prescription is sent to a licensed pharmacy partner and medication ships to your home.

Who it is for

GLP-1 programs are designed for adults seeking medically supervised weight management, often with elevated BMI or weight-related health risks. Your provider confirms eligibility based on clinical criteria, not marketing claims.

Medical workflow at a glance

1. Start Treatment (starter program payment)
2. Complete medical intake
3. Clinical review by a licensed provider
4. Prescription and fulfillment if approved
5. Optional ongoing care ($149–$199/month)

Ready to begin? Start your medical intake at /start.

Semaglutide is a GLP-1 receptor agonist used in physician-supervised weight loss programs. It works by reducing appetite and slowing gastric emptying, supporting caloric deficit when combined with lifestyle guidance from your care team.

How medical programs structure dosing

Dosing is individualized and titrated over time to improve tolerability. Programs typically start at a lower dose and increase gradually under provider oversight—not self-directed escalation. Adjustments depend on response, side effects, and concurrent medications.

Eligibility overview

Eligibility depends on BMI, comorbidities, pregnancy status, personal or family history of certain conditions, and current medications. A licensed clinician makes the final determination after reviewing your intake.

Explore our structured starter: semaglutide program intake → /start.

Qualification for GLP-1 treatment is a clinical decision. Marketing pages cannot guarantee approval; your provider applies evidence-based criteria to protect your safety.

BMI guidelines (general)

• BMI ≥ 30, or
• BMI ≥ 27 with a weight-related comorbidity (e.g., hypertension, dyslipidemia, sleep apnea)

Individual thresholds may vary based on state rules and clinical judgment.

Common contraindications

• Personal or family history of medullary thyroid carcinoma or MEN2
• Pregnancy or breastfeeding
• History of pancreatitis (case-by-case)
• Concurrent use of certain medications (reviewed in intake)

Quick checklist

• ☐ Adult seeking medically supervised weight loss
• ☐ Completed honest medical history
• ☐ No disqualifying conditions per provider review
• ☐ Understand compounded vs. brand-name options

Unsure? Start eligibility screening → /start.

Medical weight loss pricing varies widely. Brand-name GLP-1 injectables without insurance can exceed $800–$1,200 per month. Compounded options and structured telehealth programs often land in lower ranges—but quality and oversight matter as much as price.

Typical market ranges

• Brand GLP-1 (cash pay): often $800–$1,200+/month
• Telehealth starter bundles: commonly $299–$399 one-time
• Ongoing care: often $149–$199/month after starter

Why a $299–$399 starter program exists

A starter program bundles consultation, eligibility screening, prescription support if approved, and the first treatment period into one transparent payment. LYVN's starter is $349 and includes your first 30 days of medication if clinically approved—reducing surprise pharmacy fees during onboarding.

Structured medical program, not a discount coupon

You are paying for physician review, secure messaging, and pharmacy coordination—not an anonymous shipment. That structure supports safer prescribing and clearer accountability.

See pricing and begin: view starter program → /start.

The first month of a GLP-1 program focuses on onboarding, tolerability, and establishing communication with your care team—not instant results.

Onboarding process

After payment, you complete intake, receive a clinical decision within about 24 hours, and—if approved—medication typically arrives in 2–3 business days. You will receive guidance on injection technique and follow-up messaging channels.

Timeline

• Day 0: Start Treatment + intake submitted
• Day 1: Provider review in progress
• Days 2–5: Medication delivery (if approved)
• Weeks 2–4: Dose titration as directed; track symptoms

Medication adjustment expectations

Many patients titrate upward gradually. Nausea or reduced appetite early on can be common; report persistent or severe symptoms to your provider rather than stopping abruptly without guidance.

Side effects (neutral, medical framing)

GI symptoms, fatigue, or injection-site reactions may occur. Serious adverse events are uncommon but require prompt medical attention. Your program includes secure messaging for clinical questions during the first 30 days.

Begin your first month: Start Treatment → /start.